Pharma Exclusives Pressreleases
Lexicon Pharmaceuticals and Novo Nordisk Announce initiation of Phase 1 study with oral obesity drug candidate LX9851
Monday, March 23, 2026Lexicon Pharmaceuticals Inc Nasdaq LXRX and Novo Nordisk AS today announced that Novo Nordisk has initiated a Phase study with LX a firstinclass oral nonincretin development candidate
Merck and Mayo Clinic Announce New Research and Development Collaboration to Support AI-Enabled Drug Discovery and Precision Medicine
Wednesday, February 18, 2026Merck known as MSD outside of the US and Canada and Mayo Clinic the worlds topranked hospital system today announced a research and development agreement to apply artificial intelligence AI advanced analytics
Lilly to acquire Orna Therapeutics to advance cell therapies
Monday, February 09, 2026Eli Lilly and Company and Orna Therapeutics Inc a biotechnology company dedicated to engineering immune cells in vivo today announced entry into a definitive agreement for Lilly to acquire Orna
AstraZeneca enhances its weight management portfolio through collaboration agreement with CSPC Pharmaceuticals
Thursday, January 29, 2026AstraZeneca strengthens its weight management portfolio through a new strategic collaboration agreement with CSPC Pharmaceuticals to advance the development of multiple nextgeneration therapies for obesity and type diabetes
NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery In the Age of AI
Tuesday, January 13, 2026NVIDIA and Eli Lilly and Company today announced a firstofitskind AI coinnovation lab focused on applying AI to tackle some of the most enduring challenges in the pharmaceutical industry
Thermo Fisher Scientific Announces Strategic Collaboration With NVIDIA Leveraging AI to Advance Scientific Instrumentation and Accelerate Laboratory Performance
Tuesday, January 13, 2026Thermo Fisher Scientific Inc the world leader in serving science announced a strategic collaboration with NVIDIA to power AIbased solutions and laboratory automation at scale The effort will leverage the NVIDIA Artificial Intelligence
Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
Monday, January 12, 2026Teva Pharmaceuticals a US affiliate of Teva Pharmaceutical Industries Ltd NYSE and TASE TEVA and Royalty Pharma plc Nasdaq RPRX today announced a funding agreement of up to million to accelerate the clinical development of Tevas antiIL antibody TEV...
AbbVie and RemeGen Announce Exclusive Licensing Agreement to Develop A Novel Bispecific Antibody for Advanced Solid Tumors
Monday, January 12, 2026AbbVie and RemeGen today announced an exclusive licensing agreement for the development manufacturing and commercialization of RC a novel investigational Programmed Cell Death PD
Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases
Thursday, January 08, 2026Eli Lilly and Company and Ventyx Biosciences Inc Nasdaq VTYX a San Diegobased clinicalstage biopharmaceutical company focused on developing innovative oral therapies for patients with inflammatorymediated diseases
Merck to Complete Acquisition of Cidara Therapeutics
Wednesday, January 07, 2026Merck known as MSD outside of the United States and Canada today announced the successful completion of the cash tender offer through a subsidiary for all the outstanding shares of common stock of Cidara Therapeutics
